THE INTRADAY

NEO · Company KPIs

NeoGenomics (NEO) KPIs

Clinical test volume (tests performed), Average revenue per clinical test. As reported in SEC filings, with the source line for each figure.

Clinical test volume (tests performed)

367,279 for the period ended Sep 30, 2026

Dec 31, 2024: 321,679Mar 31, 2025: 326,163Jun 30, 2025: 356,630Sep 30, 2025: 360,774Dec 31, 2025: 356,136Mar 31, 2026: 345,679Jun 30, 2026: 363,498Sep 30, 2026: 367,279Dec 31, 2024Sep 30, 2026

The filings read for this page do not define this measure.

Clinical test volume (tests performed), as first reported, with the line it was read from
Period endedFigureFiling text
Sep 30, 2026367,279Number of tests performed · 367,279 · 360,774 · 1.8% · 1,076,456 · 1,043,567 · 3.2%8-K filed 2026-10-28
Jun 30, 2026363,498Number of tests performed · 363,498 · 356,630 · 1.9% · 709,177 · 682,793 · 3.9%8-K filed 2026-07-28
Mar 31, 2026345,679Number of tests performed · 345,679 · 326,163 · 6.0%8-K filed 2026-04-28
Dec 31, 2025356,136Number of tests performed · 356,136 · 321,679 · 10.7% · 1,399,703 · 1,248,740 · 12.1%8-K filed 2026-02-17
Sep 30, 2025360,774Number of tests performed · 367,279 · 360,774 · 1.8% · 1,076,456 · 1,043,567 · 3.2%8-K filed 2026-10-28
Jun 30, 2025356,630Number of tests performed · 363,498 · 356,630 · 1.9% · 709,177 · 682,793 · 3.9%8-K filed 2026-07-28
Mar 31, 2025326,163Number of tests performed · 345,679 · 326,163 · 6.0%8-K filed 2026-04-28
Dec 31, 2024321,679Number of tests performed · 356,136 · 321,679 · 10.7% · 1,399,703 · 1,248,740 · 12.1%8-K filed 2026-02-17

Average revenue per clinical test

$530 for the period ended Sep 30, 2026

Dec 31, 2024: $465Mar 31, 2025: $459Jun 30, 2025: $461Sep 30, 2025: $476Dec 31, 2025: $488Mar 31, 2026: $495Jun 30, 2026: $515Sep 30, 2026: $530Dec 31, 2024Sep 30, 2026

The filings read for this page do not define this measure.

Average revenue per clinical test, as first reported, with the line it was read from
Period endedFigureFiling text
Sep 30, 2026$530Average revenue/test · $530 · $476 · 11.3% · $514 · $465 · 10.5%8-K filed 2026-10-28
Jun 30, 2026$515Average revenue/test · $515 · $461 · 11.7% · $505 · $460 · 9.8%8-K filed 2026-07-28
Mar 31, 2026$495Average revenue/test · $495 · $459 · 7.8%8-K filed 2026-04-28
Dec 31, 2025$488Average revenue/test · $488 · $465 · 4.9% · $471 · $457 · 3.1%8-K filed 2026-02-17
Sep 30, 2025$476Average revenue/test · $530 · $476 · 11.3% · $514 · $465 · 10.5%8-K filed 2026-10-28
Jun 30, 2025$461Average revenue/test · $515 · $461 · 11.7% · $505 · $460 · 9.8%8-K filed 2026-07-28
Mar 31, 2025$459Average revenue/test · $495 · $459 · 7.8%8-K filed 2026-04-28
Dec 31, 2024$465Average revenue/test · $488 · $465 · 4.9% · $471 · $457 · 3.1%8-K filed 2026-02-17

Reading notes

Figures are shown as first reported. If a later filing prints a different figure for the same period, both appear. A figure marked ≈ or shown in words is how the company itself states it, not an estimate of ours. Companies change definitions over time, so compare periods with the quoted definition in mind. Periods that failed our checks are left out, so gaps are expected.